Thermo: FEI deal will complement mass spec portfolio 27-May-2016 By Joseph James Whitworth Thermo Fisher Scientific is to buy FEI Company for $4.2bn saying it will drive adoption of FEI’s technologies among its life sciences customers, particularly in biopharma.